Erratum to “Oral administration of Yokukansan inhibits the development of atopic dermatitis-like lesions in isolated NC/Nga mice” [J. Dermatol. Sci. 56 (2009) 37–42]

Refers to article:

Oral administration of Yokukansan inhibits the development of atopic dermatitis-like lesions in isolated NC/Nga mice Corrected Proof, 12 July 2010
Ju Jiang, Takuji Yamaguchi, Naoko Funakushi, Takatoshi Kuhara, Ping-shen Fan, Rie Ueki, Hajime Suto, Yoshio Kase, Shigaku Ikeda, Hideoki Ogawa
Journal of Dermatological Science
DOI: 10.1016/j.jdermsci.2009.07.003
Abstract | Full Text | Full-Text PDF (606 KB)

Article Outline

• Copyright

The Author regrets that when this paper was originally published, magnification details in the caption for Figure 1 were incorrect.

Figure 1 plus the correct caption are as follows:

View Large Image
Download to PowerPoint

Fig. 1. Clinical skin features and histological features of the dorsal skin in the control mice and in the mice given oral administration of Yokukansan (YKS) for 12 weeks after the start of treatment. A and D: control; B and E: 0.5% YKS; C and F: 1% YKS. D, E, and F: haematoxylin and eosin staining; Total magnification 100x.

a Atopy (Allergy) Research Center, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113-8421 Tokyo, Japan

b Department of Dermatology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113-8421 Tokyo, Japan

c Dermatology Unit, Juntendo Tokyo Geriatric Medical Center, 3-3-20 Shinsuna, Koto-ku, 136-0075 Tokyo, Japan

d Tsumura Research Laboratories, Tsumura & Co, 3586 Yoshiwara, Ami-machi, Inashiki-gun, 300-1192 Ibaraki, Japan

e Fuzhou Dermatosis Prevention and Control Hospital, 243 Xi Hong Lu, Gu Lou Qu, 350025 FuZhou, China

Corresponding author at: Atopy (Allergy) Research Center, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, 113-8421 Tokyo, Japan. Tel.: +81 3 5802 1089; fax: +81 3 3813 9443.

PII: S0923-1811(09)00328-4

doi:10.1016/S0923-1811(09)00328-4

17 of 18